P
0.446
-0.01 (-3.07%)
| Previous Close | 0.460 |
| Open | 0.465 |
| Volume | 4,384,682 |
| Avg. Volume (3M) | 421,728 |
| Market Cap | 247,157,008 |
| Price / Sales | 0.060 |
| Price / Book | 0.370 |
| 52 Weeks Range | |
| Earnings Date | 6 Nov 2024 - 11 Nov 2024 |
| Profit Margin | -4.95% |
| Operating Margin (TTM) | -8.26% |
| Diluted EPS (TTM) | -0.640 |
| Quarterly Revenue Growth (YOY) | 15.20% |
| Total Debt/Equity (MRQ) | 40.06% |
| Current Ratio (MRQ) | 0.690 |
| Return on Assets (TTM) | -12.02% |
| Return on Equity (TTM) | -41.25% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Bullish | Mixed |
| Medical Care Facilities (Global) | Bullish | Mixed | |
| Stock | P3 Health Partners Inc. | Mixed | Bearish |
Stockmoo Score
1.6
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 3.5 |
| Technical Oscillators | 0.5 |
| Average | 1.63 |
|
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Value |
| % Held by Insiders | 23.36% |
| % Held by Institutions | 23.65% |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 17 Oct 2024 | Announcement | P3 Health Partners to Present at the LD Micro Main Event XVII |
| 29 Aug 2024 | Announcement | P3 Health Partners Names Leif Pedersen New Chief Financial Officer |
| 21 Aug 2024 | Announcement | P3 Health Partners to Present at Upcoming Investor Conferences |
| 07 Aug 2024 | Announcement | P3 Health Partners Announces Second Quarter 2024 Results |
| 24 Jul 2024 | Announcement | P3 Health Partners Schedules Second Quarter 2024 Earnings Release and Conference Call |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |